Lu AA41063
Lu AA41063 is a selective adenosine A 2A receptor antagonist.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Lu AA41063 is a selective adenosine A 2A receptor antagonist. Structurally, it is a non-xanthine.
The affinities (K i ) of the drug for the human adenosine receptors are 5.9 nM for the adenosine A 2A receptor, 410 nM for the adenosine A 1 receptor (69-fold lower than for the A 2A receptor), 260 nM for the adenosine A 2B receptor (44-fold lower than for the A 2A receptor), and >10,000 nM for the adenosine A 3 receptor (>1,695-fold lower than for the A 2A receptor). Lu AA41063 was first described in the scientific literature by 2014.
Lu AA47070, a water-soluble phosphate ester prodrug of Lu AA41063, is orally active and was under development for the treatment of Parkinson's disease but was discontinued. In addition to its antiparkinsonian-like effects, Lu AA47070 reverses motivational deficits in animals and hence shows pro-motivational effects.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1328680959 under CC BY-SA 4.0; modifications have been made.